AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34919248 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactated Ringer's solution (LRS)
Number of subjects: 142
Study 34919248 — intervention group
Group type: COMPARATOR
Intervention: Normal Saline solution (NSS)
Number of subjects: 142
Study 35979636 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy
Number of subjects: 703
Study 35979636 — intervention group
Group type: COMPARATOR
Intervention: Dual antiplatelet therapy (DAPT) with ticagrelor plus aspirin
Number of subjects: 703
Study 33517104 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation plus exercise
Number of subjects: 45
Study 33517104 — intervention group
Group type: EXPERIMENTAL
Intervention: Myofascial release plus exercise
Number of subjects: 45
Study 33517104 — intervention group
Group type: COMPARATOR
Intervention: Exercise only (control)
Number of subjects: 45
Study 34103538 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 3649
Study 34103538 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3649
Study 32247530 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness and self-care program consisting of 9 weekly sessions of 90min, daily practice, and reinforcement sessions at 1 month, 3, 6, and 12 months.
Number of subjects: 314
Study 32247530 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness and self-care program
Number of subjects: 314
Study 35871140 — intervention group
Group type: EXPERIMENTAL
Intervention: Care coordination
Number of subjects: 81
Study 35871140 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 81
Study 34519769 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent hypertension management program
Number of subjects: 1432
Study 34519769 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1432
Study 33985501 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen/oxygen mixture
Number of subjects: 100
Study 33985501 — intervention group
Group type: COMPARATOR
Intervention: Oxygen therapy
Number of subjects: 100
Study 36378660 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence clubs (ACs)
Number of subjects: 220
Study 36378660 — intervention group
Group type: COMPARATOR
Intervention: Primary health care (PHC) ART clinics
Number of subjects: 220
Study 32546199 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabies vaccine
Number of subjects: 0
Study 32546199 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34418414 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental hemodialysis (twice‐weekly sessions, upwardly adjusting hemodialysis dose)
Number of subjects: 55
Study 34418414 — intervention group
Group type: COMPARATOR
Intervention: Standard hemodialysis (thrice weekly for 3.5‐4 hours, minimum Dialysis Std Kt/V of 2)
Number of subjects: 55
Study 34418414 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental hemodialysis
Number of subjects: 55
Study 34418414 — intervention group
Group type: COMPARATOR
Intervention: Standard hemodialysis
Number of subjects: 55
Study 32955013 — intervention group
Group type: EXPERIMENTAL
Intervention: Decide2Rest
Number of subjects: 73
Study 32955013 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 73
Study 32658349 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in the ASPiVLU trial
Number of subjects: 31
Study 34596225 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic preparation (Canada: Lactobacillus rhamnosus R0011/Lactobacillus helveticus R0052; US: L. rhamnosus GG)
Number of subjects: 1565
Study 34596225 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1565
Study 34596225 — intervention group
Group type: EXPERIMENTAL
Intervention: L. rhamnosus R0011/L. helveticus R0052 (among adenovirus-infected children)
Number of subjects: 1565
Study 34596225 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenovirus
Number of subjects: 1565
Study 34596225 — intervention group
Group type: EXPERIMENTAL
Intervention: Norovirus
Number of subjects: 1565
Study 34596225 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotavirus
Number of subjects: 1565
Study 34596225 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacteria
Number of subjects: 1565
Study 34214889 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of Theileria spp. (50.5%)
Number of subjects: 208
Study 34214889 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of Theileria parva (27.9%)
Number of subjects: 208
Study 34214889 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of Anaplasma marginale (19.2%)
Number of subjects: 208
Study 34214889 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of Anaplasma platys‐like (11.5%)
Number of subjects: 208
Study 34214889 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of Babesia bigemina (8.7%)
Number of subjects: 208
Study 34214889 — intervention group
Group type: EXPERIMENTAL
Intervention: Phylogenetic analysis of T. parva p104 gene
Number of subjects: 208
Study 34214889 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequencing of Theileria spp. 18S rRNA gene
Number of subjects: 208
Study 34214889 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors associated with TBPs
Number of subjects: 208
Study 33801621 — intervention group
Group type: EXPERIMENTAL
Intervention: Flywheel Resistance Training (FRT)
Number of subjects: 30
Study 33801621 — intervention group
Group type: COMPARATOR
Intervention: Traditional Strength Training (TST)
Number of subjects: 30
Study 33297761 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F‐fluoride uptake
Number of subjects: 183
Study 35072215 — intervention group
Group type: EXPERIMENTAL
Intervention: NMES with pulse width of 300 μs
Number of subjects: 46
Study 35072215 — intervention group
Group type: COMPARATOR
Intervention: NMES with pulse width of 200 μs
Number of subjects: 46
Study 33570309 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped classroom
Number of subjects: 493
Study 33570309 — intervention group
Group type: COMPARATOR
Intervention: Traditional auditorium lectures
Number of subjects: 493
Study 35149233 — intervention group
Group type: EXPERIMENTAL
Intervention: Trofinetide (200 mg/kg twice daily)
Number of subjects: 187
Study 35149233 — intervention group
Group type: EXPERIMENTAL
Intervention: Trofinetide (50, 100, and 200 mg/kg BID)
Number of subjects: 187
Study 35149233 — intervention group
Group type: EXPERIMENTAL
Intervention: Trofinetide
Number of subjects: 187
Study 33785707 — intervention group
Group type: EXPERIMENTAL
Intervention: Bean-based diet
Number of subjects: 63
Study 33785707 — intervention group
Group type: COMPARATOR
Intervention: White rice control
Number of subjects: 63
Study 35705139 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg orally per day for 12 weeks)
Number of subjects: 0
Study 33888362 — intervention group
Group type: EXPERIMENTAL
Intervention: Animated virtual healthcare assistant
Number of subjects: 1363
Study 33888362 — intervention group
Group type: COMPARATOR
Intervention: Static virtual healthcare assistant
Number of subjects: 1363
Study 33888362 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 1363
Study 36332442 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality intervention for dementia care education
Number of subjects: 39
Study 36332442 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 39
Study 35870380 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS
Number of subjects: 28
Study 35870380 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 28
Study 33839523 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus acupuncture
Number of subjects: 101
Study 33839523 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 101
Study 36479831 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR-based coaching intervention
Number of subjects: 0
Study 34429472 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval exercise (3 sets for a total of 23 min)
Number of subjects: 42
Study 34429472 — intervention group
Group type: COMPARATOR
Intervention: Rest (control group)
Number of subjects: 42
Study 34429472 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval exercise
Number of subjects: 42
Study 32501524 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-motor drill
Number of subjects: 5
Study 34371859 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric intervention with outreach team comprising a geriatrician and a dietician
Number of subjects: 147
Study 34371859 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 147
Study 34371859 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric intervention with outreach team
Number of subjects: 147
Study 32658830 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus treatment as usual (TAU)
Number of subjects: 57
Study 32658830 — intervention group
Group type: COMPARATOR
Intervention: Progressive muscle relaxation (PMR) plus treatment as usual (TAU)
Number of subjects: 57
Study 32658830 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 57
Study 34806261 — intervention group
Group type: EXPERIMENTAL
Intervention: Selexipag
Number of subjects: 1156
Study 34806261 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1156
Study 33394901 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional moderate-intensity continuous exercise program (TRAD), 30 min at 60%-80% of peak heart rate, 3 days/week for 12 weeks.
Number of subjects: 16
Study 33394901 — intervention group
Group type: EXPERIMENTAL
Intervention: Stair climbing-based high-intensity interval training program (STAIR), 3 sets of 6 flights, 3 days/week for 12 weeks.
Number of subjects: 16
Study 33524060 — intervention group
Group type: EXPERIMENTAL
Intervention: aboBoNT‐A (500 U in a 2‐mL injection volume)
Number of subjects: 134
Study 33524060 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study 33524060 — intervention group
Group type: EXPERIMENTAL
Intervention: aboBoNT‐A
Number of subjects: 134
Study 35507446 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIg continuation
Number of subjects: 60
Study 35507446 — intervention group
Group type: COMPARATOR
Intervention: IVIg withdrawal
Number of subjects: 60
Study 35507446 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined MCIDs
Number of subjects: 60
Study 32193249 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glycemic control
Number of subjects: 11071
Study 34763309 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted feeding (TRF) - limit 8 hours of eating time and fasting for 16 hours
Number of subjects: 0
Study 34763309 — intervention group
Group type: COMPARATOR
Intervention: Traditional weight-loss method - unrestricted eating time
Number of subjects: 0
Study 32186940 — intervention group
Group type: EXPERIMENTAL
Intervention: IVC injection 3 to 5 days before surgery (Group 1)
Number of subjects: 98
Study 32186940 — intervention group
Group type: EXPERIMENTAL
Intervention: IVC injection at the end of surgery (Group 2)
Number of subjects: 98
Study 32186940 — intervention group
Group type: EXPERIMENTAL
Intervention: IVC injection 3 to 5 days before and at the end of operation (Group 3)
Number of subjects: 98
Study 35964868 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure for Primary Care (PE-PC) treatment
Number of subjects: 0
Study 35964868 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study 34353774 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid recovery protocol (RP) with local infiltration of levo‐bupivacaine and supervised ambulation 4‐6 hours after surgery.
Number of subjects: 175
Study 34353774 — intervention group
Group type: COMPARATOR
Intervention: Control group with femoral nerve block and ambulation after drain removal.
Number of subjects: 175
Study 32555681 — intervention group
Group type: COMPARATOR
Intervention: 2000 NGN (Model 1)
Number of subjects: 1088
Study 32555681 — intervention group
Group type: EXPERIMENTAL
Intervention: 3000 NGN (Model 1)
Number of subjects: 1088
Study 32555681 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 NGN plus reminder call (Model 2)
Number of subjects: 1088
Study 32555681 — intervention group
Group type: EXPERIMENTAL
Intervention: 3000 NGN plus reminder call (Model 2)
Number of subjects: 1088
Study 32555681 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder calls plus CCTs
Number of subjects: 1088
Study 33982219 — intervention group
Group type: EXPERIMENTAL
Intervention: TFES + biofeedback therapy
Number of subjects: 40
Study 33982219 — intervention group
Group type: COMPARATOR
Intervention: TFES alone
Number of subjects: 40
Study 34769561 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 57
Study 34769561 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 57
Study 32730049 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive expectancy group with placebo neurofeedback
Number of subjects: 85
Study 32730049 — intervention group
Group type: COMPARATOR
Intervention: Negative expectancy group with placebo neurofeedback
Number of subjects: 85
Study 35537970 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal softening of double-lumen endobronchial tubes (DLTs) placed in 40°C 0.9% saline for 10 minutes
Number of subjects: 258
Study 35537970 — intervention group
Group type: COMPARATOR
Intervention: Non-thermal softening group (control)
Number of subjects: 258
Study 35537970 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal softening of double-lumen endobronchial tubes (DLTs)
Number of subjects: 258
Study 36508996 — intervention group
Group type: EXPERIMENTAL
Intervention: Xanthohumol (Xn) at a daily dose of 4.5 mg/kg body weight for 7 days
Number of subjects: 50
Study 36508996 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (Control)
Number of subjects: 50
Study 36508996 — intervention group
Group type: EXPERIMENTAL
Intervention: Xanthohumol (Xn)
Number of subjects: 50
Study 34543081 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 23
Study 34543081 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 32500934 — intervention group
Group type: EXPERIMENTAL
Intervention: Tripterygium wilfordii Hook F (TwHF)
Number of subjects: 20
Study 32500934 — intervention group
Group type: COMPARATOR
Intervention: Systemic glucocorticoids
Number of subjects: 20
Study 35939810 — intervention group
Group type: EXPERIMENTAL
Intervention: Ensovibep (600 mg intravenous)
Number of subjects: 485
Study 35939810 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 485
Study 35939810 — intervention group
Group type: EXPERIMENTAL
Intervention: Ensovibep
Number of subjects: 485
Study 33772154 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRINOX
Number of subjects: 330
Study 33772154 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRINOX followed by CRT
Number of subjects: 330
Study 33772154 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRINOX alone
Number of subjects: 330
Study 33772154 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRINOX +/− CRT + surgery
Number of subjects: 330
Study 33772154 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 330
Study 32569258 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for PID (current national treatment guidelines)
Number of subjects: 0
Study 35858186 — intervention group
Group type: EXPERIMENTAL
Intervention: CHECC‐uP (community‐based health literacy intervention for cancer control)
Number of subjects: 123
Study 33507248 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone (50 mg every 6 h for 9 days)
Number of subjects: 16
Study 33507248 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 34476450 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine combined with flurbiprofen axetil in addition to local anesthesia
Number of subjects: 40
Study 34476450 — intervention group
Group type: COMPARATOR
Intervention: Local anesthesia
Number of subjects: 40
Study 34476450 — intervention group
Group type: COMPARATOR
Intervention: Control group (local anesthesia)
Number of subjects: 40
Study 34476450 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (dexmedetomidine + flurbiprofen axetil)
Number of subjects: 40
Study 34955488 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy
Number of subjects: 200
Study 34955488 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy without endovascular therapy
Number of subjects: 200
Study 33711095 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated coffee consumption
Number of subjects: 390435
Study 33711095 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP)
Number of subjects: 390435
Study 33711095 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic Blood Pressure (DBP)
Number of subjects: 390435
Study 33711095 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting Heart Rate
Number of subjects: 390435
Study 32376702 — intervention group
Group type: EXPERIMENTAL
Intervention: Bezlotoxumab treatment
Number of subjects: 704
Study 36282273 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-modeled mindset intervention using videotaped interviews of former students.
Number of subjects: 917
Study 33531453 — intervention group
Group type: EXPERIMENTAL
Intervention: Beraprost sodium combined with sildenafil
Number of subjects: 80
Study 33531453 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 80
Study 35942813 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol (0.25 mcg OD)
Number of subjects: 127
Study 35942813 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study 35942813 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol
Number of subjects: 127
Study 33650888 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-Based Intervention (FBI) program
Number of subjects: 130
Study 33650888 — intervention group
Group type: COMPARATOR
Intervention: Education-only (EDU) group
Number of subjects: 130
Study 34819261 — intervention group
Group type: EXPERIMENTAL
Intervention: Serratus Anterior Plane Block (SAPB)
Number of subjects: 65
Study 34819261 — intervention group
Group type: COMPARATOR
Intervention: Intercostal Block with Incision Infiltration (IB+II)
Number of subjects: 65
Study 32422685 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 614
Study 32422685 — intervention group
Group type: COMPARATOR
Intervention: Healthy lifestyles (HL)
Number of subjects: 614
Study 36076231 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy Skills Intervention (CBTSI)
Number of subjects: 60
Study 35270556 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg/kg of caffeine (CAF-3)
Number of subjects: 10
Study 35270556 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg/kg of caffeine (CAF-6)
Number of subjects: 10
Study 35270556 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLAC)
Number of subjects: 10
Study 33369068 — intervention group
Group type: EXPERIMENTAL
Intervention: Outdoor exercise sessions
Number of subjects: 16
Study 33369068 — intervention group
Group type: COMPARATOR
Intervention: Indoor exercise sessions
Number of subjects: 16
Study 35025174 — intervention group
Group type: EXPERIMENTAL
Intervention: Oh Happy Day Class (OHDC)
Number of subjects: 132
Study 35025174 — intervention group
Group type: COMPARATOR
Intervention: Coping with Depression (CWD)
Number of subjects: 132
Study 32977741 — intervention group
Group type: EXPERIMENTAL
Intervention: FibroScan
Number of subjects: 0
Study 32977741 — intervention group
Group type: EXPERIMENTAL
Intervention: VTQ
Number of subjects: 0
Study 32977741 — intervention group
Group type: COMPARATOR
Intervention: FIB-4 index
Number of subjects: 0
Study 32977741 — intervention group
Group type: COMPARATOR
Intervention: M2BPGi
Number of subjects: 0
Study 35933224 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutrophil-to-lymphocyte ratio (NLR)
Number of subjects: 0
Study 32299437 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-incentivised Test n Treat
Number of subjects: 509
Study 32299437 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentivised Test n Treat
Number of subjects: 509
Study 32299437 — intervention group
Group type: EXPERIMENTAL
Intervention: Projected daily capacity for screening
Number of subjects: 509
Study 35134221 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 0
Study 32179560 — intervention group
Group type: EXPERIMENTAL
Intervention: Early adenotonsillectomy (AT)
Number of subjects: 460
Study 32179560 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting with supportive care (WWSC)
Number of subjects: 460
Study 34392411 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 IU of daily vitamin D3
Number of subjects: 98
Study 34392411 — intervention group
Group type: EXPERIMENTAL
Intervention: 4000 IU of daily vitamin D3
Number of subjects: 98
Study 32718193 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol as maintenance and reliever therapy
Number of subjects: 2010
Study 32718193 — intervention group
Group type: COMPARATOR
Intervention: Budesonide/formoterol maintenance plus terbutaline as reliever
Number of subjects: 2010
Study 34001426 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental Intervention Group (EIG)
Number of subjects: 59
Study 34001426 — intervention group
Group type: COMPARATOR
Intervention: Control Intervention Group (CIG)
Number of subjects: 59
Study 32953229 — intervention group
Group type: EXPERIMENTAL
Intervention: C1INH (SC) 40 or 60 IU/kg twice weekly for 52-140 weeks
Number of subjects: 10
Study 35105177 — intervention group
Group type: EXPERIMENTAL
Intervention: SXC
Number of subjects: 628
Study 35105177 — intervention group
Group type: COMPARATOR
Intervention: Losartan
Number of subjects: 628
Study 33792003 — intervention group
Group type: EXPERIMENTAL
Intervention: Topically administered heparin
Number of subjects: 50
Study 33792003 — intervention group
Group type: COMPARATOR
Intervention: Control ointment (dexpanthenol)
Number of subjects: 50
Study 33728429 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation
Number of subjects: 218
Study 33728429 — intervention group
Group type: COMPARATOR
Intervention: Antiarrhythmic drugs (AAD)
Number of subjects: 218